Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 2 single-arm, open-label trial of volasertib with its proprietary PPMP for the treatment of relapsed/refractory acute myelogenous leukaemia (r/r AML)

Next Previous
X
Search
Trial Profile

A phase 2 single-arm, open-label trial of volasertib with its proprietary PPMP for the treatment of relapsed/refractory acute myelogenous leukaemia (r/r AML)

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 25 Jul 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Volasertib (Primary)
  • Indications Acute myeloid leukaemia
  • Focus Therapeutic Use

    • Most Recent Events

    • 24 Jul 2024 According to a Notable Labs media release, the company expects to have initial data from the dose optimization lead-in during the fourth quarter of 2024, initiate selective enrollment of PMP-predicted responders after that, and start to report initial efficacy results during H1 2025.
    • 24 Jul 2024 According to a Notable Labs media release, the company announced progress for the Phase 2 volasertib program following receipt of "Clearance to Proceed" from the FDA and agreement on the dosing plan for its Phase 2 clinical trial and intends to initiate enrollment in coming months.
    • 10 Apr 2024 Trial design, presented at the 115th Annual Meeting of the American Association for Cancer Research

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top